Position in AZN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$345,298
-$13,839 QoQ
Shares Held
1,821
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#989
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GREATMARK INVESTMENT PARTNERS, INC. holds $72,037,606 across 8 Drug Manufacturers - General names. AZN ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
114,692 | $29,128,327 | |
| 2 | AMGN |
Amgen Inc
|
71,294 | $25,816,983 | |
| 3 | ABBV |
AbbVie Inc.
|
36,732 | $9,243,240 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
28,312 | $3,576,938 | |
| 5 | LLY |
ELI LILLY & Co
|
2,673 | $3,206,076 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,806 | $489,071 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
1,821 | $345,298 | |
| 8 | PFE |
Pfizer Inc
|
9,621 | $231,673 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,298 | 1,821 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $359,137 | 1,821 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||